Abeona Therapeutics Inc (NASDAQ:ABEO) - Share price


Stock Report

Abeona Therapeutics Inc ABEO

Last Price
$-

Day Change
-|-%

As of -
- | USD
Minimum 15 Minutes Delay.

Last Close-
Day Range-
Mkt Cap260.30Mil
52-Wk Range-
Yield %-
ISINUS00289Y1073
Volume-
P/E-
P/S-
P/CF-

Share Price

Financials
201720182019
More ...
Income Statement
Revenue0.843.000.00
Operating Income-27.84-58.17-77.09
Net Income-27.32-56.67-76.28
Basic EPS-0.66-1.19-1.51
Avg. Diluted Shares Outstanding424850
Balance Sheet
Current Assets140.5988.85132.39
Non Current Assets38.1785.5590.99
Total Assets178.77174.40223.38
Current Liabilities5.6120.3538.70
Total Liabilities8.6740.3544.95
Total Equity170.10134.05178.43
Cash Flow
Operating Cash Flow-22.94-39.11-62.82
Capital Expenditure-0.86-19.49-6.51
Free Cash Flow-23.80-58.61-69.33

In millions, except "Basic EPS". Currency is USD.

Company Profile

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

88
Key Stats
More ...
Price/Earning TTM-
Price/Book-
Price/Sales TTM-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % TTM-Infinity
Net Margin % TTM-Infinity
ROE TTM-48.82
Debt/Equity0.04
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.